Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Children's Cancers | Ependymoma
Age: Between 1 - 21 Years
Gender: Male or Female
Patients must be newly diagnosed with histologically confirmed intracranial ependymoma; patients with classic ependymoma (WHO II) or anaplastic ependymoma (WHO III) are eligible, as are various subtypes described as clear cell, papillary, cellular or a combination of the above
Patients with evidence of metastatic disease will be excluded
Patients with a diagnosis of spinal cord ependymoma, myxopapillary ependymoma, subependymoma, ependymoblastoma, or mixed glioma are NOT eligible
No prior treatment other than surgical intervention and corticosteroids; patients are allowed to have had more than one attempt at resection prior to enrollment
Pregnant female patients are not eligible for this study
Post-menarchal females may not participate unless a pregnancy test with a negative result has been obtained
Males and females of reproductive potential may not participate unless they have agreed to use an effective contraceptive method
Lactating females may not participate unless they have agreed not to breastfeed a child while on this study
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required